Previous Page  6 / 9 Next Page
Information
Show Menu
Previous Page 6 / 9 Next Page
Page Background

Page 32

Journal of Clinical Immunology and Allergy

ISSN: 2471-304X

16

th

EuroSciCon Conference on

Immunology

M a r c h 1 1 - 1 2 , 2 0 1 9

Am s t e r d a m , N e t h e r l a n d s

Immunology 2019

Objective:

Intestinal amebiasis is still an important health problem in developing

countries of the world. One of the most issues for future biomedical research

is the development of antimicrobial resistant, in order to search for alternative

new antiamoebic drugs. A study was carried out to evaluate the efficacy of

albendazol on the viability of

Entamoeba histolytica

clinical isolate from human

which used for experimental animals.

Material and Methods:

All experimental animal models (30 albino mice and 30

rabbits),divided into 3 groups,each group with either 10 mouse or 10 rabbits,

were orally infected with

E. histolytica

(clinical isolate), then after 7 days

they were given drugs (Metronidazol or Albendazol) daily according to body

weight prepared in advance for 5 days duration and in addition to the controls

without drugs. Stool specimens of each group were examined microspically

for viable trophozoites,and the number of these trophozoites were counted

with haemocytometer chamber, as compared to untreated and treated groups.

Statistical methods used was student t-test.

Results:

The results showed infection of

E.histolytica

was able to be intiated

in rabbits only. Albendazol and metronidazol were highly effective(100%) on

treatment of infected groups of rabbits ( table I ). Trphozoites of

E. histolytica

was highly sensitive to albendazol (25% viability), or to metronidazol (22.7%

viability) at a dose of 400 mg / kg / day and 250 mg / kg / day respectively,which

was significant in relation to the control 500% viability(table II). However, the

differences were significant at the level (p<o.o1).

Conclusions:

The present study showed that the newly used albendazol is very

effective anti-amebic drug as metronidazol in rabbits.

Biography

Abdulsalam Mohamad Kasim Al-Mukhtar has completeted his

Ph.D. at age 37 years, from Salford University (England 1980),

more than 30 research published in different journals,and

he was working as lecturer in dept. of microbiologl,college of

medicine, university of Mosul,Mosul, Iraq for 44 years ago.

salam_1943@yahoo.com

Effectienevss of Albendazol against Viability of

Entamoeba

histolytica

in experimental animals

AbdulSalam M. Al-Mukhtar

Dept. of Microbiology,College of Medicine, University of Mosul, IRAQ

AbdulSalam M. Al-Mukhtar, J Clin Immunol Allergy 2019, Volume:5

DOI: 10.21767/2471-304X-C1-008